Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 9-12 October 2017One generic medicine recommended for approvalThe ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

FDA

Johnson & Johnson (JNJ) PT Raised to $142 at Stifel on 3Q Earnings Report; 'Pharma Carries the Day, Hurricane Headwinds Encouragingly ModestOctober 17, 2017 5:16 PM AstraZeneca (AZN) Reports FDA Acceptance of Supplemental Biologics License Application for IMFINZI (Durvalumab)October 17, 2017 7:04 AM